Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
The long-term effectiveness of specific immunotherapy in cat allergy: a real-life study.
Immunotherapy·2026
Same author
Successful oral desensitization to temozolomide in a patient with immediate hypersensitivity reaction.
Cancer chemotherapy and pharmacology·2026
Same author
Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.
The Lancet. Respiratory medicine·2026
Related Experiment Video
Updated: Apr 7, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.7K
[Acute exacerbation in COPD and asthma].
Nurhayat Yıldırım1, Tunçalp Demir, Bilun Gemicioğlu
1Department of Chest Diseases, Faculty of Cerrahpasa Medicine, Istanbul University, Istanbul, Turkey. nurhayatyil@hotmail.com.
Tuberkuloz Ve Toraks
|July 14, 2015
Summary
Acute exacerbations significantly impact chronic obstructive pulmonary disease (COPD) and asthma. Prevention strategies include smoking cessation, infection control, and appropriate inhaler therapies for COPD, while asthma management focuses on trigger avoidance and adherence to inhaled corticosteroids.
More Related Videos
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) and asthma are chronic airway diseases characterized by acute exacerbations.
- Exacerbations significantly alter the natural disease course for both conditions.
Purpose of the Study:
- To review the causes and prevention strategies for exacerbations in COPD and asthma.
- To outline the essential treatment components for managing exacerbations in these respiratory diseases.
Main Methods:
- Literature review of factors contributing to COPD and asthma exacerbations.
- Analysis of preventive measures and therapeutic approaches for exacerbation management.
Main Results:
- COPD exacerbations are multifactorial, including infections, pollution, and comorbidities. Prevention involves smoking cessation, infection control, and medications like long-acting bronchodilators and inhaled corticosteroids.
- Asthma exacerbations are triggered by allergens, infections, and environmental factors. Prevention emphasizes trigger avoidance, managing comorbidities, and consistent use of inhaled corticosteroids.
- Core treatments for both COPD and asthma exacerbations include bronchodilators and steroids to address inflammation. Specific causative treatments are also crucial.
Conclusions:
- Effective management of COPD and asthma exacerbations requires a multifaceted approach.
- Prevention strategies tailored to each disease, alongside prompt and appropriate treatment, are vital for improving patient outcomes and reducing disease burden.